None listed
Conditions
Brief summary
The aim of the research is to test a values-guided diabetes self-management intervention for adolescents and young adults with type 1 diabetes (T1D). The single-arm pilot study (n=20) will quantify the impact of the intervention on short-term glycaemic control (i.e., time in range, 3.9-10.0 mmol/L). We will recruit patients ages 18-25 years with a T1D diagnosis and under the care of Southern District Health Board diabetes services. It is hypothesized that time in range will increase from pre- to post-intervention, but there is not enough previous research to hypothesize a percentage increase.
Interventions
The brief intervention for improving diabetes (BIFID) aims to motivate sustainable behaviour change by connecting self-management with self-chosen values. The intervention will follow a protocol to achieve key tasks: 1) identify the participant’s values, 2) identify how diabetes has been a barrier to valued living, 3) provide education on coping with diabetes-specific barriers to valued living, 4) create an action plan to change one diabetes-specific behaviour. The education on coping strategies and the action plan will be tailored to the individual based on their self-reported barriers. Participants may receive one or more single-paged handouts to reinforce how to practice a new coping strategy. Handouts will be selected from the Acceptance and Commitment Therapy literature (e.g., Harris https://www.actmindfully.com.au/free-stuff/worksheets-handouts-book-chapters/; Hayes & Ciarrochi https://thrivingadolescent.com/adolescent-resources/thriving-adolescent-book-downloads/). Adherence to the action plan will be assessed at the 4-week post-intervention study visit. The intervention will be delivered in a single 30 to 60-minute session face-to-face (e.g., clinical setting, participant’s home) or via teleconference by a health practitioner (medical doctor) or health researcher. The individual delivering the intervention will have knowledge of type 1 diabetes management and training in Acceptance and Commitment Therapy.
Sponsors
Study design
Eligibility
Inclusion criteria
1. Diagnosed with type 1 diabetes for at least 6 months 2. Most recent HbA1c is at least 58 mmol/mol 3. English fluency
Exclusion criteria
1. Any severe uncontrolled comorbidities 2. Participation in a study that may affect glucose levels